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O B J E C T I V E S The aim of the present study was to compare lesion morphologies after sirolimus-
eluting stent (SES) implantation between patients with unstable angina pectoris (UAP) and stable angina
pectoris (SAP) with the use of optical coherence tomography (OCT).
B A C KG ROUND The lesion morphologies before and after coronary stenting have been proposed as
important predictors of clinical outcome. The high resolution of OCT provides detailed information of
coronary vessel wall.
METHOD S We enrolled 55 patients (UAP: n  24, SAP: n  31), and examined lesion morphologies
by using OCT at pre- and post-SES implantation and 9 months’ follow-up.
R E S U L T S The incidence of plaque rupture (42% vs. 3%, p 0.001), intracoronary thrombus (67% vs. 3%,
p  0.001) and thin-capped ﬁbroatheroma (cap thickness 65 m; 46% vs. 3%, p  0.001) at pre-
intervention was signiﬁcantly greater in UAP than that in SAP. Although stent proﬁles and procedural
characteristics were not different between the 2 groups, inadequate stent apposition (67% vs. 32%, p 
0.038) and tissue protrusion (79% vs. 42%, p  0.005) after percutaneous coronary intervention were
observed more frequently in patients with UAP. Plaque rupture was signiﬁcantly increased after percutane-
ous coronary intervention in patients with UAP (42% to 75%, p  0.018), and the persistence of core cavity
after plaque rupture (28% vs. 4%, p  0.031) at 9 months’ follow-up was observed more frequently in UAP
patients compared with SAP patients. At 9 months’ follow-up, the incidence of inadequately apposed stent
(33% vs. 4%, p 0.012) and partially uncovered stent by neointima (72% vs. 37%, p 0.019) was signiﬁcantly
greater in UAP patients than that in SAP patients. All patients took aspirin and ticlopidine during follow-up
period, and no patients had stent thrombosis or adverse coronary events.
CONC L U S I O N S Serial OCT examinations demonstrated markedly different vascular response up
to 9 months after SES implantation between UAP and SAP patients. Although the inadequate lesion
morphologies after stenting were observed more frequently in UAP patients, these ﬁndings were not
associated with adverse outcomes in patients with antiplatelet therapy. (J Am Coll Cardiol Img 2008;
1:475–84) © 2008 by the American College of Cardiology Foundation
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476ercutaneous coronary intervention (PCI) with
the use of sirolimus-eluting stent (SES) is an
effective treatment for patients with acute coro-
nary syndromes (ACS) (1). The main contribu-
ion of SES is to reduce the need for target-vessel
evascularization (2). However, sirolimus has been
eported to impair local vascular healing with de-
ayed endothelization (3), and the patients with
CS, compared to those with stable angina
See page 485
ectoris (SAP), present a greater risk for thrombotic
omplication after SES implantation (4). There-
ore, vascular response after SES implantation in
he vulnerable lesion is a great concern. Recently,
ntravascular optical coherence tomography (OCT)
as been developed as a high-resolution (10 to 20
m) imaging modality (5). In the present study, we
performed serial OCT examination before
and after PCI and at 9 months’ follow-up
to compare lesion morphology after SES
implantation between patients with unsta-
ble angina pectoris (UAP) and SAP.
M E T H O D S
Study population. The patients with UAP
(Braunwald class III-B) or symptomatic
SAP were enrolled. Angiographic inclu-
sion criteria were: 1) an identifiable and de
novo culprit lesion in a native coronary
artery; and 2) good candidates for PCI.
Exclusion criteria were as follows: 1) con-
traindications to SES implantation; 2)
ulprit lesion in the left main coronary artery or the
smium of the right, left anterior descending, or
ircumflex coronary artery; 3) bifurcation lesion; 4)
hronic total occlusion; 5) making it difficult to
dvance the OCT catheter; 6) making the OCT
xamination difficult; 7) congestive heart failure
ith left ventricular ejection fraction 40%; and 8)
enal insufficiency with baseline serum creatinine
1.5 mg/dl. Demographic and clinical data were
rospectively collected. The institutional review
oard approved the study, and all patients provided
nformed consent before participation.
CT image acquisition. Aspirin (100 mg), ticlopi-
ine (200 mg), and intravenous heparin (100 U/kg)
ere administered before coronary catheterization.
oronary catheterization was performed by the
onventional femoral approach using a 6-F sheath
ome
und
y
s
t
orisnd catheters. The OCT evaluation was performed cefore and after PCI and at 9 months’ follow-up.
he technique of OCT imaging has been described
reviously (6,7). In brief, a 0.016-inch OCT cath-
ter (Image Wire, Light Lab Imaging, Westford,
assachusetts) was advanced to the distal end of
he culprit lesion through a 3-F occlusion balloon
atheter. To remove the blood from the field of
iew, occlusion balloon was inflated to 0.6 atm at
roximal site of the culprit lesion, and lactate
inger’s solution was infused into coronary artery
rom distal tip of the occlusion balloon catheter at
.5 ml/s. The entire length of the culprit lesion was
maged with an automatic pullback device moving
t 1 mm/s. During the pullback of OCT catheter,
he images were captured at an acquisition rate of
5 frames/s and recorded digitally. Percutaneous
oronary intervention was performed in a standard
anner. The selections of balloon and SES
Cypher, Cordis Corp. Johnson & Johnson, Miami
akes, Florida) size were based on intravascular
ltrasound (IVUS) findings.
CT image analysis. The OCT images were ana-
yzed by 2 independent observers who were blinded
o the clinical presentations. When there was dis-
ordance between the observers, a consensus read-
ng was obtained. The corresponding images of
erial OCT examination were identified by the
istances from 2 landmarks, such as side branches
nd stent edges. The OCT images were analyzed
ith validated criteria for plaque characterization as
eported previously (6,8). Before PCI, plaque rup-
ure was identified by a presence of fibrous cap
iscontinuity and a cavity formation within the
laque (6,8). Fibrous cap thickness was measured at
he thinnest part. Lipid was semiquantified as the
umber of involved quadrants on the cross-
ectional image. When lipid was present in 2
uadrants within a plaque, it was considered a
ipid-rich plaque. Thin-cap fibroatheroma (TCFA)
as defined as a plaque with lipid content in 2
uadrants and the thinnest part of a fibrous cap
easuring 65 m. After PCI, inadequate stent
pposition, tissue protrusion, intracoronary throm-
us, stent edge dissection, and plaque rupture
aused by PCI were evaluated by the use of OCT.
he inadequate stent apposition was defined as 1 or
ore stent struts clearly separated from the vessel
all (7). When the distance between stent inner
urface reflection and the vessel wall was150 m,
he stent strut was identified as clearly separated (7).
issue protrusion was defined as a tissue prolapse
etween stent struts extending inside a circular arcB B R E V I A T I O N S
N D A C R O N YM S
CS acute coronary syndr
VUS intravascular ultraso
CT optical coherence
omography
CI percutaneous coronar
ntervention
AP stable angina pectori
ES sirolimus-eluting sten
CFA thin-capped
broatheromaonnecting adjacent struts (5). Thrombus was iden-
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477ified as an intraluminal mass discontinuing from
he surface of the vessel wall that had a signal-free
hadow in the OCT image (9). Stent edge dissec-
ion was defined as arterial disruption adjacent to
he stent where a flap of tissue could be clearly
ifferentiated from the underlying plaque (5).
Representative OCT images obtained after PCI
ere shown in Figure 1. At 9 months’ follow-up,
he stent struts were assessed every 1 mm within the
tented segment and classified into 1 of the 3
ategories (Fig. 2) as reported previously (7): 1)
ell-apposed to vessel wall with apparent neointi-
al coverage; 2) well-apposed to vessel wall without
Figure 1. Representative OCT Images of Stented Lesions After P
(A-1) OCT-visualized inadequate stent strut apposition (arrows). (A-
stent struts was observed in OCT image (arrow). (B-2) It was not ev
as intraluminal mass images with signal-free shadow by OCT (arrow
at the site of stent edge was demonstrated by OCT (arrows). (D-2)
intravascular ultrasound; OCT  optical coherence tomography; PC
Figure 2. Representative OCT Images of SES at 9 Months’ Follow
(A-1, A-2) OCT-visualized stent struts and neointimal hyperplasia cle
gories. (B-2) The strut was well-apposed to vessel wall and covered
not covered by neointima. (B-4) The struts were inadequately appo
coherence tomography; SES  sirolimus-eluting stent.eointimal coverage; and 3) inadequately apposed
o the vessel wall without neointimal coverage.
urthermore, residual ruptured plaque defined by
he persistence of core cavity in the stented segment
as evaluated (Fig. 3). The areas of stent, lumen,
nd neointimal hyperplasia were also measured
very 1 mm within the stented segment; volumes
ere calculated with the use of Simpson’s rule.
nterobserver and intraobserver variabilities were as-
essed by the evaluation of all images.
VUS image analysis. IVUS (Atlantis SR Pro 2.5F,
0-MHz, Boston Scientific, Natick, Massachu-
etts) examination was performed with an auto-
nd Corresponding IVUS Images
was not shown clearly on IVUS. (B-1) Tissue protrusion between
t in the IVUS image. (C-1) Intracoronary thrombi were identiﬁed
C-2) They were not detected by IVUS. (D-1) Coronary dissection
documented dissection (5 o’clock) and clot (2 o’clock). IVUS 
percutaneous coronary intervention.
p
. (B-1) Each stent strut was classiﬁed into one of the three cate-
neointima. (B-3) The struts were well-apposed to vessel wall and
to vessel wall and not covered by neointima. OCT  opticalCI a
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478atic pullback device at a rate of 0.5 mm/s. The
orresponding images of OCT and IVUS were
dentified by the distances from 2 landmarks, such
s side branches and stent edges. The IVUS analysis
as performed according to the criteria of the
merican College of Cardiology Clinical Expert
onsensus document on IVUS (10). Inadequate
tent apposition, tissue protrusion, intracoronary
hrombus, and stent edge dissection were noted in
he qualitative analysis. Quantitative measurements
ncluded vessel area, lumen area, plaque area, lesion
ength, and remodeling index. Positive remodeling
as defined as a remodeling index 1.0.
uantitative coronary angiographic analysis. Quanti-
ative coronary angiography was conducted with the
ardiovascular Measurement System (CMS-
EDIS Medical Imaging System, Leiden, the
etherlands). The reference diameter, minimal lu-
inal diameter, and diameter stenosis were calcu-
ated by an independent operator. In addition, late
umen loss was calculated both in-stent and in the
ntire analysis segment, also including the 5-mm
roximal and distal stent margins (also called
n-segment).
ntiplatelet regimen and clinical follow-up. Aspirin
00 mg/day and ticlopidine 200 mg/day were ad-
inistrated in all patients during follow-up period.
linical status was assessed at hospital discharge
nd every month after the procedure. The 9
onths’ follow-up was an office visit together with
xercise electrocardiogram testing.
tatistical analysis. Categorical data are presented as
ncidences and compared with chi-square statistics
r the Fisher exact test. The Fisher exact test was
Figure 3. Serial OCT Images of the Culprit Lesion in UAP Before
(A) OCT demonstrated the lipid-core (LC) with calcium (Ca) before P
The plaque was ruptured by PCI (*). Stent struts were not well-app
observed (9 o’clock). (C) At 9 months’ follow-up, OCT showed persisten
neointimal coverage. OCT  optical coherence tomography; PCI  pesed if there was an expected cell value 5. Con- vinuous variables are presented as mean  SD and
ompared with the use of an unpaired or paired t
est. Intraobserver and interobserver variabilities
ere measured by  test of concordance. All analysis
equired a p  0.05 for statistical significance.
E S U L T S
tudy patients. A total of 70 patients were consec-
tively enrolled in the study. Fifteen patients were
xcluded because the OCT imaging was not per-
ormed according to exclusion criteria (n  12), the
mage quality precluded analysis (n  2), or the
quipment malfunctioned (n 1). In the remaining
5 patients with successful OCT imaging, 24 pa-
ients presented with UAP, and 31 patients with
AP. Mean follow-up period was 9.2  0.9
onths. Ten patients refused the angiographic and
CT follow-up. Therefore, the follow-up OCT
xamination was performed in 18 patients with
AP and 27 patients with SAP.
atient characteristics. Patient characteristics at
aseline are demonstrated in Table 1. Minimum
umen diameter (0.5  0.2 mm vs. 0.7  0.3 mm,
 0.015) and minimum lumen area (2.7  0.7
m2 vs. 3.0  0.5 mm2, p  0.034) were signifi-
antly smaller in UAP patients compared with SAP
atients. The incidence of positive remodeling
67% vs. 31%, p  0.021) was significantly greater
n UAP patients. Coronary risk factors, distributions
f the culprit vessel, and PCI procedures were com-
arable between the 2 groups.
CT ﬁndings. The OCT findings before PCI are
hown in Table 2. Incidence of plaque rupture (42%
I, After PCI, and at 9 Months’ Follow-Up
Fibrous cap was disrupted (arrow) at the tiniest part (30 m). (B)
to the core cavity and vessel wall. Intracoronary thrombus was
f core cavity (**) and inadequately-apposed stent struts without
neous coronary intervention; UAP  unstable angina pectoris.PC
CI.
osed
ce os. 3%, p  0.001), intracoronary thrombus (67% vs.
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479%, p  0.001), and lipid-rich plaque (71% vs. 42%,
 0.031) in UAP was significantly greater than
hat in SAP. Fibrous cap thickness (73 19 m vs.
96  58 m, p  0.001) was significantly thinner
n UAP, and there was a significant difference in the
ncidence of TCFA (46% vs. 3%, p  0.001)
etween 2 groups.
The comparison of lesion morphologies after
CI between patients with UAP and SAP is
emonstrated in Figure 4. Although the incidence
f stent edge dissection was similar in both groups,
he incidence of inadequate stent apposition (67%
s. 32%, p  0.038), tissue protrusion (79% vs.
2%, p  0.005) and intracoronary thrombus (83%
s. 23%, p  0.001) in patients with UAP was
ignificantly greater than that in patients with SAP.
n the assessment of the relationship between the
re-PCI lesion morphology with the post-PCI
esponses to stenting, the lesions with plaque rup-
ure, thrombus, lipid-rich plaque, or TCFA (n 
8), compared with lesions without these OCT
eatures (n  37), showed high incidence of inad-
quate stent apposition (83% vs. 30%, p  0.001),
issue protrusion (94% vs. 41%, p  0.001), and
ntracoronary thrombus (100% vs. 24%, p 0.001).
n addition, using OCT, we were able to visualize
hese inadequate stent features more frequently
han when using IVUS (Table 3).
The findings of serial OCT examination are
ummarized in Table 4. Plaque rupture was in-
reased by PCI in UAP patients (42% to 75%, p 
.018) but not changed in SAP patients. After PCI,
he incidence of the ruptured plaque was signifi-
antly greater in patients with UAP compared to
atients with SAP (75% vs. 13%, p  0.001).
lthough the ruptured plaque decreased during
ollow-up in UAP (75% to 28%, p  0.002), the
ncidence of the residual ruptured plaque at 9
onths’ follow-up was significantly greater in UAP
atients than that in SAP patients (28% vs. 4%, p
.031) (Fig. 5). The inadequate stent apposition
lso decreased during follow-up period in UAP
67% to 33%, p  0.032) and SAP (32% to 4%,
 0.007) patients. At the follow-up, the inci-
ence of inadequate stent apposition was signifi-
antly greater in UAP compared with SAP patients
33% vs. 4%, p  0.012). The incidence of tissue
rotrusion at the follow-up was not different be-
ween the 2 groups. The stent edge dissection and
ntracoronary thrombus was not observed in both
roups at 9 months’ follow-up.
The OCT assessment of neointimal coverage of
tent strut at 9 months’ follow-up is demonstrated an Table 5. In 911 cross-sectional OCT images,
,532 stent struts were evaluated. The mean num-
er of struts with neointimal coverage in each stent
as not different between UAP and SAP patients.
he mean number of well-apposed struts without
eointimal coverage (19.0  18.1 vs. 6.6  11.3,
 0.007) and the mean number of inadequately
Table 1. Baseline Characteristics
UAP
(n  24) (n
Age, yrs 68 9 72
Male 17 (71) 18
Coronary risk factor
Hypertension 20 (83) 24
Diabetes mellitus 10 (42) 10
Hypercholesterolemia 14 (58) 17
Smoking 13 (27) 15
Obesity 15 (63) 16
Culprit vessel
LAD 9 (38) 13
LCx 3 (12) 4
RCA 12 (50) 14
QCA analysis
Reference diameter, mm 3.2 0.2 3.1
Minimum lumen diameter, mm 0.5 0.2 0.7
Diameter stenosis, % 81 12 77
IVUS analysis
Proximal reference segment
EEM CSA, mm2 13.0 2.1 12.5
Lumen CSA, mm2 8.2 1.2 8.0
Lesion segment
EEM CSA, mm2 13.5 2.2 12.8
Lumen CSA, mm2 2.7 0.7 3.0
Plaque CSA, mm2 10.8 2.5 9.8
Positive remodeling, % 16 (67) 11
Lesion length, mm 16.9 3.2 16.2
Calcium arc, ° 30 36 38
Distal reference segment
EEM CSA, mm2 10.7 1.4 10.4
Lumen CSA, mm2 7.7 1.1 7.4
PCI procedure
Stent diameter, mm 3.2 0.3 3.1
Stent length, mm 21 4 20
Direct stenting 3 (13) 1
After inﬂation 24 (100) 31
Balloon size, mm 3.3 0.3 3.2
Maximum inﬂation pressure, atm 15.6 1.4 15.7
Stent-to-artery ratio 1.03 0.07 1.04
Follow-up, months 9.3 0.8 9.2
Values are given as n (%) or mean  SD.
CSA  cross-sectional area; EEM  external elastic membrane; IVUS  intrava
left anterior descending coronary artery; LCx  left circumﬂex artery; PCI 
intervention QCA  quantitative coronary angiography; RCA  right coronary ar
pectoris; UAP  unstable angina pectoris.SAP
 31)
p
Value
 7 0.088
(58) 0.329
(77) 0.584
(32) 0.473
(55) 0.332
(33) 0.671
(52) 0.418
0.135
(42)
(13)
(45)
 0.3 0.105
 0.3 0.015
 8 0.166
 1.9 0.412
 1.0 0.555
 2.5 0.292
 0.5 0.034
 2.6 0.151
(31) 0.021
 3.3 0.441
 34 0.396
 1.7 0.544
 1.2 0.281
 0.3 0.845
 3 0.601
(3) 0.307
(100) N/A
 0.3 0.782
 1.4 0.847
 0.09 0.895
 1.0 0.730
scular ultrasound; LAD 
percutaneous coronary
tery; SAP  stable anginapposed struts without neointimal coverage (4.0 
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480.7 vs. 0.2  1.2, p  0.006) were significantly
reater in UAP patients compared with SAP pa-
ients. In quantitative OCT analysis, percent vol-
me of neointimal hyperplasia (10.9  3.0 vs. 13.8
4.5, p  0.025) and percent mean area of
eointimal hyperplasia (10.9  3.0 vs. 13.6  4.1,
 0.029) were significantly smaller in UAP than
hose in SAP (Table 6). The incidence of SES
eaturing full coverage of every strut by neointima
as significantly lower (28% vs. 63%, p  0.019) in
AP, and the incidence of SES containing partially
ncovered strut lesions was significantly greater
72% vs. 37%, p  0.019) in UAP compared with
AP patients. The changes of the lesion findings
rom pre- to post-PCI to 9 months after SES
quate Stent
position
Tissue
Protrusion
Intracoronary 
Thrombus
Stent Edge
Dissection
UAP
SAP
quate Stent
position
Tissue
Protrusion
Intracoronary 
Thrombus
Stent Edge
Dissection
UAP
SAP
US Findings After PCI in UAP and SAP Patients
, although the incidence of stent edge dissection was not differ-
SAP, the incidence of inadequate stent apposition (*p  0.038),
0.005) and intracoronary thrombus (‡p  0.001) in UAP was sig-
that in SAP. (B) In the IVUS analysis, the incidence of inadequate
enting was similar in both groups. IVUS  intravascular ultra-
coherence tomography; PCI  percutaneous coronary interven-
CT Findings Before PCI in UAP and SAP Patients
UAP (n  24) SAP (n  31) p Value
ture 10 (42) 1 (3) 0.001
16 (67) 1 (3) 0.001
plaque 17 (71) 13 (42) 0.031
p thickness, m 73 19 196 58 0.001
11 (46) 1 (3) 0.001
iven as n (%) or mean  SD.
tical coherence tomography; TCFA  thin-cap ﬁbroatheroma; other abbrevia-
able 1.p
ina pectoris; UAP  unstable angina pectoris.mplantation in UAP and SAP are diagramed in
igure 6.
linical and angiographical outcomes. PCI was suc-
essful in all patients. No complications occurred
uring OCT imaging. All patients took aspirin and
iclopidine during the follow-up period, and they
id not have any adverse coronary events. None of
atients had an evidence of ischemia in the exercise
lectrocardiogram testing at 9 months’ follow-up.
urthermore, none of patients with follow-up cor-
nary catheterization had angiographic restenosis
nd target vessel revascularization. In the follow-up
ngiography, in-stent percent diameter stenosis (6.4
3.3% vs. 6.8  3.9%, p  0.765), in-segment %
iameter stenosis (7.2  2.8% vs. 7.4  3.6%, p 
.813), in-stent late loss (0.13  0.33 vs. 0.14 
.32, p  0.957) and in-segment late loss (0.15 
.35 vs. 0.14  0.34, p  0.935) were not different
etween UAP and SAP patients.
ntraobserver and interobserver variability. Intraob-
erver variability yielded acceptable concordance for
nadequate stent apposition (  0.90), tissue
rotrusion (  0.92), intracoronary thrombus (
0.94), stent edge dissection (  0.96), and
esidual ruptured plaque (  0.92). Interobserver
ariability showed relatively lower concordance for
nadequate stent apposition (  0.75), tissue
rotrusion (  0.86), intracoronary thrombus (
0.87), stent edge dissection (  0.89), and
esidual ruptured plaque (  0.86).
I S C U S S I O N
his is the first OCT study to compare vascular
esponses after SES implantation between UAP
nd SAP patients. The major findings of our
nalysis are as follows: 1) The incidence of plaque
upture, intracoronary thrombus, and TCFA in
atients with UAP was significantly greater than
hat in patients with SAP. 2) Although the stent
nd procedural characteristics were not different
etween the 2 groups, the incidence of inadequate
tent apposition and tissue protrusion after PCI was
ignificantly greater in patients with UAP. 3)
laque rupture was significantly increased by PCI in
AP patients, and the residual ruptured plaque at 9
onths’ follow-up was observed more frequently in
AP compared to SAP patients. 4) The incidence
f inadequately-apposed stent and partially uncov-
red stent by neointima at 9 months’ follow-up was
ignificantly greater in UAP compared to SAP(%)
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481ted with adverse outcomes in patients with strict
ntiplatelet therapy during 9 months’ follow-up.
dentiﬁcation of vulnerable plaque by OCT. Vulner-
ble plaques constitute direct precursor lesions giv-
ng rise to coronary thrombosis. An autopsy study
uggested that plaque rupture accounted for 60%
f all intracoronary thrombi associated with sudden
ardiac death (11). For plaque rupture, the mor-
hology resembling vulnerable plaque has been
escribed as TCFA. Recently, we reported that
CT allowed us to detect the fibrous cap disrup-
ion in 73% of acute myocardial infarction, which
as similar to that in pathohistological examination
6). Jang et al. (8) demonstrated a greater prevalence
f TCFA in patients with ACS (55%) compared
ith SAP (18%). The present OCT study showed
hat the frequency of intracoronary thrombus was
lso greater in UAP patients than that in SAP
atients. These OCT findings supported our un-
erstanding of the pathophysiology of coronary
rtery disease. Although OCT is limited in the
uantification of lipid-core, it might be a useful
odality to evaluate the intrinsic features that
etermine plaque vulnerability in vivo.
ssessment of coronary stenting with OCT. Intravas-
ular ultrasound is the gold standard for the assess-
ent of coronary intervention. Cheneau et al. (12)
howed that the post-intervention IVUS identified
t least one of the abnormal findings, such as
nadequate stent apposition, dissection, or throm-
us, in 78% of patients with subacute stent throm-
osis and identified multiple findings in 48% of the
atients. Considering the high resolution of OCT,
t is not surprising to observe an increased frequency
nd detail in the detection of small stent features.
ouma et al. (5) demonstrated that OCT, com-
ared with IVUS, detected inadequate stent appo-
ition (17% vs. 7%), tissue protrusion (69% vs.
9%), and dissection (19% vs. 5%) more frequently
fter stent implantation. However, these subtle
ndings by OCT may not be clinically relevant
egardless of clinical presentation, lesion character-
stics or stent type. The quantification or grading of
he findings may be important to predict lesion
utcomes after PCI.
ES implantation in the vulnerable lesion. The pivotal
linical registry demonstrated that the SES implan-
ation were useful and safe in ACS (1). However,
he ACS patients, compared to SAP patients, still
ave a greater risk for in-stent thrombosis, and this
readed complication remains a major cause of
eath and morbidity (4). On the basis of the reliable
VUS reports, the large ulceration of the ruptured(%)
Pre-PCI 
(UAP=24, SAP=31)
Post-PCI
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Figure 5. Incidence of the Ruptured Plaque Assessed With OCT Before and After PCI
and at 9 Months’ Follow-Up in UAP and SAP Patients
Ruptured plaque in UAP was increased by PCI (*p  0.05), and decreased during 9
months’ follow-up (†p  0.005). In SAP, it was not changed after PCI and during follow-
up. The incidence of the ruptured plaque was signiﬁcantly greater in UAP than that inTable 3. OCT and IVUS Findings for Corresponding Images After PCI
OCT (n  55) IVUS (n  55) p Value
Inadequate stent apposition 26 (47) 10 (18) 0.001
Tissue protrusion 32 (58) 11 (20) 0.001
Thrombus 27 (49) 5 (9) 0.001
Stent edge dissection 22 (40) 9 (16) 0.005
Values are given as n (%).Table 4. Serial OCT Analysis
Before PCI After PCI
9 Months’
Follow-Up
UAP
No. of lesions 24 24 18
Plaque rupture 10 (42) 18 (75)* 5 (28)*
Thrombus 16 (67) 20 (83)* 0 (0)
Inadequate stent apposition — 16 (67)* 6 (33)*
Tissue protrusion — 19 (79)* 1 (6)
Stent edge dissection — 9 (38) 0 (0)
SAP
No. of lesions 31 31 27
Plaque rupture 1 (3) 4 (13) 1 (4)
Thrombus 1 (3) 7 (23) 0 (0)
Inadequate stent apposition — 10 (32) 1 (4)
Tissue protrusion — 13 (42) 2 (7)
Stent edge dissection — 13 (42) 0 (0)
Values are given as n (%). *p  0.05 vs. SAP.SAP before and after PCI and 9 months’ follow-up (‡p  0.05).
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482laque might result in stent malapposition (12), and
he soft plaque composition was thought to be high
isk for tissue protrusion (13). A pathohistological
tudy also demonstrated that breaching and pene-
ration of a necrotic core might lead to the exposure
f thrombogenic lipid content to flowing blood
14). Furthermore, the recent clinical studies sug-
ested that SES could delay vascular healing. Mat-
umoto et al. (7) showed by OCT that almost 10%
f the individual stent struts were not covered by
eointima at 6 months after SES implantation.
wata et al. (15) demonstrated the presence of
hrombi and yellow plaques even as much as 2 years
fter SES implantation by coronary angioscopy.
hese features can potentially increase the risk of
hrombotic complications after SES implantation,
specially in patients with ACS. The present OCT
tudy demonstrated a greater incidence of inade-
uate stented lesion findings in UAP patients com-
ared with SAP patients after SES implantation
nd 9 months’ follow-up. These findings were not
ssociated with adverse outcomes in patients with
trict antiplatelet therapy. However, the withdrawal
f antiplatelet therapy has been reported to be a
Table 5. OCT Assessment for Neointimal Coverage of Stent Stru
UAP (n
No. of struts with neointimal coverage 145.2
No. struts without neointimal coverage
Well-apposed struts 19.0
Inadequately-apposed struts 4.0
Values are given as mean  SD.
Abbreviations as in Tables 1 and 2.
Table 6. Quantitative OCT Analysis in Stented Segments After P
UAP (n
After PCI
Stent volume, mm3 224.4
Lumen volume, mm3 222.8
Mean stent area, mm2 10.5
Mean lumen area, mm2 10.4
9 month’s follow-up
Stent volume, mm3 209.7
Lumen volume, mm3 187.0
Intimal hyperplasia volume, mm3 22.6
% intimal hyperplasia volume, % 10.9
Mean stent area, mm2 10.0
Mean lumen area, mm2 8.9
Mean intimal hyperplasia area, mm2 1.1
% intimal hyperplasia area, % 10.9
Values are given as mean  SD.
Abbreviations as in Tables 1 and 2.ignificant risk factor for stent thrombosis in pa-
ients with SES implantation (16). The poorly
ealed sites of SES implantation may pose a sig-
ificant risk for coronary thrombosis when anti-
latelet therapy is abruptly discontinued. In addition,
he vascular responses to SES versus bare-metal stents
ay differ according to clinical presentation or lesion
haracteristics. However, because the present study
nly included the lesions treated with SES, these
bservations can not be extrapolated to lesions in UAP
r SAP patients treated with bare-metal stents.
tudy limitations. There were several limitations in
he present study. First, an inherent limitation of the
resent OCT system is need to remove the blood
rom the field of view for clear image acquisition,
hich was achieved through lactate Ringer’s solution
ushes during coronary occlusion by balloon catheter.
herefore, it was not able to observe ostial lesions of
oronary artery. Second, a further limitation of OCT
s the relatively shallow axial penetration. The vessels
ith reference diameter of 4 mm were excluded in
his study. Third, the present study was a single-center
CT examination with a small sample size. Larger
t 9 Months’ Follow-Up in UAP and SAP Patients
8) SAP (n  27) p Value
.5 160.0 35.1 0.189
.1 6.6 11.3 0.007
0.2 1.2 0.006
nd at 9 Months’ Follow-Up in UAP and SAP Patients
8) SAP (n 2 7) p Value
.4 199.4 48.7 0.121
.1 197.8 48.5 0.118
9.8 1.8 0.172
9.7 1.8 0.167
.2 189.3 44.5 0.184
.2 164.0 42.4 0.108
24.7 7.2 0.357
13.8 4.5 0.025
9.1 1.7 0.086
8.0 1.7 0.060
1.1 0.3 0.571
13.6 4.1 0.029ts a
 1
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6.7CI a
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483ohorts study with longer-term follow-up will be
ecessary to confirm our findings.
onclusions. Serial OCT findings demonstrated
arkedly different vascular response up to 9 months
fter SES implantation between UAP and SAP
atients. Although the inadequate lesion morphol-
gies after stenting were observed more frequently
Figure 6. Changes of the Lesion Findings Before and After PCI
Plaque and Stable Plaque
(A) The ruptured plaque has a core cavity, and the thick-cap ﬁbroat
stent struts were not well-apposed to the vessel wall. Furthermore,
PCI. At 9 months’ follow-up, the ruptured plaque cavity was persist
neointima. (B) The thick-cap ﬁbroatheroma was not ruptured during
covered by neointima at 9 months’ follow-up. Figure illustrations dotion of sirolimus-eluting stents com-
pared with conventional bare stent 2004;109:190 –5.ngs were not associated with adverse outcomes in
atients with antiplatelet therapy.
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